Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Howes

Showing results (431-440 of 443) with videos related to

Pageof 45
Sort By:
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Dopaminergic-related Anatomical Pattern of Dorsal Striatum in SchizophreniaChao Xie, Shitong Xiang, Yueyuan Zheng, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Dopamine and schizophrenia from bench to bedside: Discovery of a striatal co-expression risk gene set that predicts in vivo measures of striatal functionLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.
Nature Communications|April 30, 2024
Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivoLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.
The Lancet. Psychiatry|December 3, 2023
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysisSpyridon Siafis, Lasse Brandt, Robert A McCutcheon, et al.
Journal of Medicinal Chemistry|February 3, 2007
Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidateMartin J Slater, Elizabeth M Amphlett, David M Andrews, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 2023
Multi-omics data integration methods and their applications in psychiatric disordersAnita Sathyanarayanan, Tamara T Mueller, Mohammad Ali Moni, et al.
Psychopharmacology|February 25, 2022
Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorderStephanie M Y Wong, Y N Suen, Charlotte W C Wong, et al.
Schizophrenia Bulletin|September 10, 2020
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)Alice Egerton, Anna Murphy, Jacek Donocik, et al.
Wellcome Open Research|July 22, 2024
Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human dataSpyridon Siafis, Virginia Chiocchia, Malcolm R Macleod, et al.
Pageof 45

Showing results (431-440 of 443) with videos related to

Sort By:
Pageof 45
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Dopaminergic-related Anatomical Pattern of Dorsal Striatum in SchizophreniaChao Xie, Shitong Xiang, Yueyuan Zheng, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Dopamine and schizophrenia from bench to bedside: Discovery of a striatal co-expression risk gene set that predicts in vivo measures of striatal functionLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.
Nature Communications|April 30, 2024
Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivoLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.
The Lancet. Psychiatry|December 3, 2023
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysisSpyridon Siafis, Lasse Brandt, Robert A McCutcheon, et al.
Journal of Medicinal Chemistry|February 3, 2007
Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidateMartin J Slater, Elizabeth M Amphlett, David M Andrews, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 2023
Multi-omics data integration methods and their applications in psychiatric disordersAnita Sathyanarayanan, Tamara T Mueller, Mohammad Ali Moni, et al.
Psychopharmacology|February 25, 2022
Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorderStephanie M Y Wong, Y N Suen, Charlotte W C Wong, et al.
Schizophrenia Bulletin|September 10, 2020
Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)Alice Egerton, Anna Murphy, Jacek Donocik, et al.
Wellcome Open Research|July 22, 2024
Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human dataSpyridon Siafis, Virginia Chiocchia, Malcolm R Macleod, et al.
Pageof 45